WebCategory Toxicity Code CTCAE v5.0 Term CTCAE v5.0 Toxicity Codes Gastrointestinal disorders 10017947 Gastrointestinal disorders ‐ Other, specify Gastrointestinal disorders … WebFeb 23, 2024 · Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 Published: May 28, 2009 (v4.03: June 14, 2010) US DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Institutes of Health, ... Since kidney toxicity is not uncommon with these agents, it is mandatory for clinicians to become familiar with these …
(PDF) The Safety and Efficacy of the Repeated PRRT with
WebBackground: The Kidney Disease: Improving Global Outcomes group (KDIGO) defined acute kidney injury (AKI) as an elevation of serum creatinine (sCR) exceeding 0.3 mg/dl within 48 h. The widely used adverse events criteria for chemotherapy, Common Toxicity Criteria for Adverse Events Version 4.0 (CTCAE v4.0), also defined AKI as sCR … WebThe mean absorbed kidney dose in 228 patients was 20.1 ± 4.9 Gy. Conclusion: Nephrotoxicity in patients treated with (177)Lu-octreotate was low. No (sub)acute grade … smart clinic wales
2 Characterization of Renal Toxicity - National Center for ...
WebApr 14, 2024 · The adverse events were evaluated by the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 5.0. ... anemia, thrombocytopenia, and mucositis. In our study, we did not observe grade 3 and 4 renal toxicity or encephalopathy. According to the report of Weigel et al., ... WebMay 10, 2016 · Acute and long-term renal toxicity assessment was done according to Common Terminology Criteria for Adverse Events (CTCAE v4.0) . Hypertension was defined as the use of antihypertensive drugs (thiazide diuretics, beta blockers, ACE inhibitors, angiotensin II receptor antagonists and calcium channel blockers). WebNov 25, 2024 · This prospective study investigated the impact of cabozantinib exposure on proteinuria and muscle toxicity, in a cohort of 14 Japanese patients with unresectable hepatocellular carcinoma (uHCC). We measured the trough concentration of cabozantinib (Ctrough) weekly for 6 weeks after starting treatment. Although the initial dose was less … smart clinics adelaide street brisbane